Susceptibilities of Propionibacterium acnes ophthalmic isolates to moxifloxacin [1]

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 10, 2001, Pages 2969-2970

  Dali, P ^a   Giugliano, E R ^a   Vellozzi, E M ^a   Smith, M A ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; CLINDAMYCIN; MACROLIDE; MOXIFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; SPARFLOXACIN;

ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; BACTERIUM ISOLATE; ENDOPHTHALMITIS; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES;

ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; PROPIONIBACTERIUM ACNES; QUINOLINES;

EID: 0034801767     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.10.2969-2970.2001     Document Type: Letter

References (7)

1. Evaluation of the E test for susceptibility testing of anaerobic bacteria
2. Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria
3. Bay 12-8039, a new 8-methoxy-quinolone: Comparative in vitro activity with nine other antimicrobials against anaerobic bacteria
4. Susceptibility testing of Propionibacterium acnes comparing agar dilution with E test